No quarterly revenue total was found in IB ACQUISITION CORP.'s SEC filings.
Ib Acquisition Corp. (IBAC) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research.
Revenue
—
Net income
$-567,166
-169.3% vs year-ago quarter
Operating cash flow
$-474,473
-235.7% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
5.01M
-68.2% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- IBAC (Nasdaq), IBACR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Boca Raton, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1998781
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$624,429 | -$748,177 | -$180,000 | -$236,772 | -$172,210 |
| Net income | -$567,166 | -$639,866 | -$58,902 | $866,365 | $818,610 |
| Operating cash flow | -$474,473 | -$265,850 | -$1.1M | -$57,319 | -$141,357 |
| Total assets | $8.5M | $8.5M | $16.4M | $17.1M | $122.2M |
| Total liabilities | $2.4M | $1.8M | $1.2M | $1.8M | $549,009 |
| Stockholders' equity | -$2.3M | -$1.7M | -$861,323 | -$681,323 | $599,661 |
| Cash and investments | $30,161 | $4,634 | $165,484 | $428,700 | $486,018 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 4, 2026 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 6, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 30, 2026 | Sep 24, 2026 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Sep 23, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 21, 2026 | Sep 15, 2026 |
All 90 Ib Acquisition Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.